C-Diff: Stopping the Spread

From my morning reading feed, here’s a slightly different take. We already know that Vancomycin and Fidoxamycin have show superior clinical results (i.e. better cure rate, less chance of relapse) than Metronidazole, which is why treatment guidelines have changed. And of course that’s important to us as individual patients. But according to this study, treating with Vancomycin or Fidoxamycin is also better for decreasing transmission because they decrease shedding of spores more quickly than Metronidazole. That’s important in hospitals and assisted living facilities especially. So, these treatment options are better for individual patients and better for the community. #research